CoChat

Rationally designed AAV2 and AAVrh8R capsids provide improved transduction in the retina and brain

The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.

Abstract

The successful application of adeno-associated virus (AAV) gene delivery vectors as a therapeutic paradigm will require efficient gene delivery to the appropriate cells in affected organs. In this study, we utilized a rational design approach to introduce modifications to the AAV2 and AAVrh8R capsids and the resulting variants were evaluated for transduction activity in the retina and brain. The modifications disrupted either capsid/receptor binding or altered capsid surface charge. Specifically, we mutated AAV2 amino acids R585A and R588A, which are required for binding to its receptor, heparan sulfate proteoglycans, to generate a variant referred to as AAV2-HBKO. In contrast to parental AAV2, the AAV2-HBKO vector displayed low-transduction activity following intravitreal delivery to the mouse eye; however, following its subretinal delivery, AAV2-HBKO resulted in significantly greater photoreceptor transduction. Intrastriatal delivery of AAV2-HBKO to mice facilitated widespread striatal and cortical expression, in contrast to the restricted transduction pattern of the parental AAV2 vector. Furthermore, we found that altering the surface charge on the AAVrh8R capsid by modifying the number of arginine residues on the capsid surface had a profound impact on subretinal transduction. The data further validate the potential of capsid engineering to improve AAV gene therapy vectors for clinical applications.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41434-018-0017-8

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 56 references

Cited by

See all 38

Metadata

Authors
Sullivan, J. A., Stanek, L. M., Lukason, M. J., Bu, J., Osmond, S. R., Barry, E. A., O’Riordan, C. R., Shihabuddin, L. S., Cheng, S. H., & Scaria, A.
Corresponding author
Sullivan, Jennifer A.
Venue
Gene Therapy
Published
2018-05-22
Volume
25
Issue
3
Pages
205-219
ISSN
  • 0969-7128 (ISSN-L)
  • 1476-5462
OpenAlex
W2804837468
Cited by
37
References
57
Citations by year
2026: 6 · 2025: 2 · 2024: 5 · 2023: 2 · 2022: 6 · 2021: 2 · 2020: 8 · 2019: 5 · 2018: 1
FWCI
2.45
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Gene Therapy (publishedVersion)
  • PubMed (publishedVersion)
Funders
Sanofi
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
Keywords
adeno-associated virus vectors, AAV2, capsid engineering, arginine residues, retinal gene delivery, phototransduction, subretinal delivery, gene therapy vectors
MeSH terms
Dependovirus, Animals, Brain, Capsid, Genetic Vectors, HeLa Cells, Heparan Sulfate, Humans, Mice, Inbred C57BL, Photoreceptor Cells, Retina, Transduction, Genetic, Genetic Therapy, Gene Transfer Techniques, Parvovirinae, Capsid Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rationally designed AAV2 and AAVrh8R capsids provide improved transduction in the retina and brain. https://app.cochat.ai/papers/10.1038/s41434-018-0017-8
The paper
Sullivan, J. A., Stanek, L. M., Lukason, M. J., Bu, J., Osmond, S. R., Barry, E. A., O’Riordan, C. R., Shihabuddin, L. S., Cheng, S. H., & Scaria, A. (2018). Rationally designed AAV2 and AAVrh8R capsids provide improved transduction in the retina and brain. Gene Therapy. https://doi.org/10.1038/s41434-018-0017-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.